Opportunity Information: Apply for RFA IP 13 002
Apply for RFA IP 13 002
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Epidemiology, Prevention and Treatment of Influenza and other Respiratory Infections in Panama and Central America Region" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Dec 19, 2012 and posted on Dec 19, 2012.
- Applicants must submit their applications by Feb 15, 2013 Application Due Date February 15, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $5,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Gorgas Memorial Institute for Health Studies (GMI) Avenida Justo Arosemena y Calle 35 APDO. 0816 02593 Panama, Republica de Panama 2. Foreign Organizations Foreign Organizations are eligible to apply. Foreign components of U.S. Organizations are eligible to apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Epidemiology, Prevention and Treatment of Influenza and other Respiratory Infections in Panama and Central America Region" is a CDC-funded cooperative agreement designed to build and strengthen regional public health capacity focused on influenza and other important respiratory and emerging infections. Its central purpose is to improve the ability of Panama and neighboring Central American countries to detect and characterize outbreaks, describe patterns of illness, and carry out applied studies that explain how these infections spread, how much disease they cause, and what their broader economic impact looks like. Beyond surveillance and burden estimation, the opportunity emphasizes practical evaluation work, including assessing new or improved diagnostic tools, vaccines, antiviral therapies, risk assessment approaches, and other interventions that could prevent infections or reduce illness severity and complications.
The scope of work, as described, is wide but clearly targeted: it supports activities that help countries in the region generate reliable epidemiologic evidence on transmission dynamics, clinical disease outcomes, and the societal costs associated with influenza and other respiratory pathogens of public health concern, including emerging and re-emerging infectious diseases. The intent is not only to count cases, but to develop stronger systems and scientific capability to investigate respiratory disease threats in real time and to test which prevention and treatment options are most effective and feasible in local settings. Because the award is structured as a cooperative agreement, the CDC would be expected to have substantial involvement in the funded work, typically meaning close technical collaboration, shared planning, and ongoing guidance rather than a hands-off grant relationship.
Administratively, this was a discretionary funding opportunity in the health category, posted on December 19, 2012, with an application due date of February 15, 2013, and an archive date of March 17, 2013. The program anticipated making a single award (ExpectedAwards: 1). The estimated total funding amount was $5,000,000, with an award ceiling of $1,000,000 and an award floor of $100,000, indicating the possible annual or project-period range for the single recipient depending on the final cooperative agreement structure and budget approvals. There was no cost sharing or matching requirement. The funding is associated with CFDA number 93.283, under the CDC program area described as "Investigations and Technical Assistance," which aligns with the applied epidemiology and evaluation focus laid out in the description.
Eligibility was oriented toward foreign entities and regional partners. The announcement explicitly identifies the Gorgas Memorial Institute for Health Studies (GMI) in Panama as an eligible applicant, and it also states that foreign organizations are eligible to apply, as are foreign components of U.S. organizations. This framing reflects the regional capacity-building objective and the need for strong in-country institutions capable of conducting surveillance, field epidemiology, clinical and laboratory investigations, and evaluations of interventions across Panama and the Central America region.
For applicants needing assistance accessing the full announcement at the time, the listed point of contact was the CDC Procurement and Grants Office (PGO), Technical Information Management Section (TIMS), reachable by phone at 770-488-2700. The opportunity notice also indicates that the detailed announcement content was accessed through the "Full Announcement" link in the original posting environment, with the additional information link text noting it was not an active standalone link.
Frequently Asked Questions (FAQs)
What is the official title of this grant opportunity?
The opportunity is titled "Epidemiology, Prevention and Treatment of Influenza and other Respiratory Infections in Panama and Central America Region."
Which federal agency is funding this opportunity?
This is a CDC-funded cooperative agreement.
What type of funding mechanism is it?
It is a cooperative agreement, which means CDC is expected to have substantial involvement in the funded work (for example, close technical collaboration, shared planning, and ongoing guidance).
What is the main purpose of the cooperative agreement?
The central purpose is to build and strengthen regional public health capacity focused on influenza and other important respiratory and emerging infections in Panama and neighboring Central American countries.
What public health outcomes is this funding intended to improve?
The opportunity is intended to improve the region's ability to detect and characterize outbreaks, describe patterns of illness, and carry out applied studies on how infections spread, how much disease they cause, and their broader economic impact.
Which diseases or threats does the scope include?
The scope includes influenza and other important respiratory infections, as well as emerging and re-emerging infectious diseases of public health concern.
Is the focus limited to surveillance and case counting?
No. While surveillance and burden estimation are included, the scope emphasizes generating reliable epidemiologic evidence and strengthening systems and scientific capability to investigate respiratory disease threats in real time.
What kinds of studies and evaluations are emphasized?
The opportunity emphasizes applied studies and practical evaluation work, including assessing new or improved diagnostic tools, vaccines, antiviral therapies, risk assessment approaches, and other interventions that could prevent infections or reduce illness severity and complications.
What kinds of data or evidence is this funding meant to help produce?
It supports work to generate epidemiologic evidence on transmission dynamics, clinical disease outcomes, and societal costs associated with influenza and other respiratory pathogens of public health concern.
What geographic region is the work focused on?
The cooperative agreement is focused on Panama and the Central America region (including neighboring Central American countries).
How many awards were expected to be made?
The program anticipated making a single award (ExpectedAwards: 1).
What was the estimated total funding amount?
The estimated total funding amount was $5,000,000.
What were the award floor and award ceiling?
The award floor was $100,000 and the award ceiling was $1,000,000.
Does this opportunity require cost sharing or matching funds?
No. The announcement stated there was no cost sharing or matching requirement.
What is the CFDA number associated with this funding?
The associated CFDA number is 93.283.
What CDC program area is this opportunity associated with?
It is under the CDC program area described as "Investigations and Technical Assistance," aligning with the applied epidemiology and evaluation focus described in the opportunity.
Who was eligible to apply?
Eligibility was oriented toward foreign entities and regional partners. The announcement explicitly identified the Gorgas Memorial Institute for Health Studies (GMI) in Panama as an eligible applicant. It also stated that foreign organizations are eligible to apply, as are foreign components of U.S. organizations.
Is the Gorgas Memorial Institute for Health Studies (GMI) specifically named as eligible?
Yes. The Gorgas Memorial Institute for Health Studies (GMI) in Panama was explicitly identified as an eligible applicant.
Are foreign organizations eligible?
Yes. The announcement stated that foreign organizations are eligible to apply.
Are foreign components of U.S. organizations eligible?
Yes. The announcement stated that foreign components of U.S. organizations are eligible to apply.
When was the opportunity posted?
It was posted on December 19, 2012.
What was the application due date?
The application due date was February 15, 2013.
When was the opportunity archived?
The archive date was March 17, 2013.
What category was the opportunity listed under?
It was a discretionary funding opportunity in the health category.
What does "CDC substantial involvement" mean in this context?
Because this is a cooperative agreement, CDC would be expected to play an active role through close technical collaboration, shared planning, and ongoing guidance, rather than providing funding with a hands-off relationship.
Where could applicants find the full announcement details?
The notice indicated that the detailed announcement content was accessed through the "Full Announcement" link in the original posting environment. It also noted that the additional information link text was not an active standalone link.
Who was the listed point of contact for help accessing the announcement?
The listed point of contact was the CDC Procurement and Grants Office (PGO), Technical Information Management Section (TIMS).
What phone number was provided for the point of contact?
The phone number provided was 770-488-2700.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: DARPA BAA 13 11 Vetting Commodity IT Software and Firmware
Previous opportunity: Environmental Studies Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA IP 13 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA IP 13 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Grants to States to Support Oral Health Workforce Activities Apply for HRSA 13 142 Funding Number: HRSA 13 142 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Partnering with the Ministry of Health of Vietnam to Build a Sustainable System for HIV/AIDS Prevention, Care, and Treatment in the Socialist Republic of Vietnam under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1304 Funding Number: CDC RFA GH13 1304 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $12,000,000 |
| NIDCD Clinical Research Center Grant (P50) Apply for PAR 13 062 Funding Number: PAR 13 062 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nationwide Program for National and State Background Checks for Direct Patient Access Employees of Long Term Care Facilities and Providers Apply for CMS 1A1 13 001 Funding Number: CMS 1A1 13 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $3,000,000 |
| Interdisciplinary Complementary and Integrative Health Clinical Research Training Award (T90/R90) Apply for PAR 13 065 Funding Number: PAR 13 065 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening the Monitoring and Evaluation of Programs for the Elimination and Control of Neglected Tropical Diseases in Africa Apply for RFA GH 13 002 Funding Number: RFA GH 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $9,000,000 |
| Exemplar Health Information Exchange Governance Entities Program Apply for HIEGE HG 12 001 Funding Number: HIEGE HG 12 001 Agency: Office of the National Coordinator Category: Health Funding Amount: $400,000 |
| Research in latent tuberculosis infection (LTBI) in the setting of HIV Co Infection (R01) Apply for PAR 13 061 Funding Number: PAR 13 061 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrating Newborn Screening Long term Follow up into Primary Care Practices Apply for HRSA 13 213 Funding Number: HRSA 13 213 Agency: Health Resources and Services Administration Category: Health Funding Amount: $110,000 |
| Limited Competition Initiative to Maximize Research Education in Genomics (R25) Diversity Action Plan Apply for PAR 13 063 Funding Number: PAR 13 063 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Building healthcare practitioner capacity around HPV Vaccine Communication Apply for RFA IP 13 001 Funding Number: RFA IP 13 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Revisions for Macromolecular Interactions in Cells (R01) Apply for RFA GM 14 003 Funding Number: RFA GM 14 003 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| Telehealth Resource Center Grant Program Apply for HRSA 13 167 Funding Number: HRSA 13 167 Agency: Health Resources and Services Administration Category: Health Funding Amount: $325,000 |
| Implementation Support for State Demonstrations to Integrate Care for Medicare Medicaid Enrollees Apply for CMS 1I1 13 001 Funding Number: CMS 1I1 13 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $15,000,000 |
| Sober Truth on Preventing Underage Drinking Act Grants Apply for SP 13 001 Funding Number: SP 13 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $50,000 |
| The CDCs National Undergraduate Student Program A Public Health Workplace Experience to Increase Student Interest in Public Health Apply for CDC RFA MN11 1101 Funding Number: CDC RFA MN11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,850,000 |
| FY 2013 Cooperative Agreements for the National Suicide Prevention Lifeline Crisis Center Follow Up Apply for SM 13 002 Funding Number: SM 13 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $60,000 |
| Planning Grants for Expansion of the Comprehensive Community Mental Health Services for Children and Their Families Apply for SM 13 001 Funding Number: SM 13 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $800,000 |
| Support of Competitive Research (SCORE) Research Advancement Award (SC1) Apply for PAR 13 069 Funding Number: PAR 13 069 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Support of Competitive Research (SCORE) Pilot Project Award (SC2) Apply for PAR 13 070 Funding Number: PAR 13 070 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA IP 13 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.